Montco biopharm raises $20M Series B funding round
September 25, 2020 at 13:12 PM EDT
The company's initial target is a rare inherited condition that afflicts an estimated 130,000 people in the United States.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|